Allina Health study could save breast cancer patients time, money and side effects

(Allina Health ) The study was designed to determine the tumor and patient characteristics which predicted lower risk of breast cancer recurrence in women with invasive lobular carcinoma. Classic ILC is more likely to respond to edocrine treatment than chemotherapy.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news